Small molecule drug discovery for glioblastoma treatment based on bioinformatics and cheminformatics approaches

Small molecule drug discovery for glioblastoma treatment based on bioinformatics and cheminformatics approaches

Background: Glioblastoma (GBM) is a common and highly aggressive brain tumor with a poor prognosis for patients. It is urgently needed to identify potential small molecule drugs that specifically target key genes associated with GBM development and prognosis.Methods: Differentially expressed genes (...

Full description

Bibliographic Details
Main Authors:	Liya Feng, Sha Zhu, Jian Ma, Jing Huang, Xiaoyan Hou, Qian Qiu, Tingting Zhang, Meixia Wan, Juan Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Pharmacology
Subjects:	glioblastoma multi-omics data bioinformatics therapeutic agents ADMET molecular docking
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1389440/full

Similar Items

RNA editing in glioblastoma: A predictive model based on integrated bioinformatics analysis
by: Xiaobin Luo, et al.
Published: (2025-01-01)

Investigating the relevance of nucleotide metabolism in the prognosis of glioblastoma through bioinformatics models
by: Lu-Wei Jiang, et al.
Published: (2025-02-01)

Key Cell-in-Cell Related Genes are Identified by Bioinformatics and Experiments in Glioblastoma
by: Zhang F, et al.
Published: (2024-09-01)

Identification of novel prognostic targets in glioblastoma using bioinformatics analysis
by: Xiaofeng Yin, et al.
Published: (2022-04-01)

Identification of BST2 Contributing to the Development of Glioblastoma Based on Bioinformatics Analysis
by: Yang Kong, et al.
Published: (2022-07-01)

Combined machine learning models, docking analysis, ADMET studies and molecular dynamics simulations for the design of novel FAK inhibitors against glioblastoma
by: Yihuan Zhao, et al.
Published: (2024-10-01)

Editorial: Experimental and computational aspects of bioactive proteins from animal venoms: an insight into pharmacological properties and drug discovery
by: Michelle Khai Khun Yap, et al.
Published: (2024-02-01)

Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations
by: Amany Belal, et al.
Published: (2022-08-01)

Integrative bioinformatic analysis to identify potential phytochemical candidates for glioblastoma
by: Hafiza Maria Usmani Rana, et al.
Published: (2024-12-01)

The role and application of bioinformatics techniques and tools in drug discovery
by: Shujun Zhang, et al.
Published: (2025-02-01)

Bioinformatics analysis of differential expression of CD44 in glioblastomas and cell experimental validation
by: SUN Xu, LI Shunshun, WANG Dianheng, WANG Zhenfeng
Published: (2024-06-01)

Editorial: Use of computational tools for designing epigenetic drugs
by: Yudibeth Sixto-López, et al.
Published: (2024-02-01)

Glioblastoma organoid technology: an emerging preclinical models for drug discovery
by: Don Carlo Ramos Batara, et al.
Published: (2022-02-01)

Design of New Derivatives of Dimedone Molecules Using QSAR and Docking Molecular
by: Khaoula Mkhayar, et al.
Published: (2022-11-01)

Bioinformatics analysis of photoexcited natural flavonoid glycosides as the inhibitors for oropharyngeal HPV oncoproteins
by: Maryam Pourhajibagher, et al.
Published: (2024-03-01)

Bioinformatics Strategies to Identify Shared Molecular Biomarkers That Link Ischemic Stroke and Moyamoya Disease with Glioblastoma
by: Md Khairul Islam, et al.
Published: (2022-07-01)

Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical Data
by: Dimitra Smerdi, et al.
Published: (2024-05-01)

Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses
by: Shengda Ye, et al.
Published: (2022-09-01)

The bioinformatics landscape in environmental omics: Lessons from a national ELIXIR survey
by: Anastasia Gioti, et al.
Published: (2024-06-01)

Integrative multi-omics characterization reveals sex differences in glioblastoma
by: Byunghyun Jang, et al.
Published: (2024-03-01)

Synthesis, in silico modelling, and in vitro biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agents
by: Samuel T. Boateng, et al.
Published: (2023-12-01)

QSAR ANALYSIS USING SEMI-EMPIRICAL AM1 METHOD, MOLECULAR DOCKING, AND ADMET STUDIES OF CHALCONE DERIVATIVES AS ANTIMALARIAL COMPOUNDS
by: Muhammad Akbar S Kurniawan, et al.
Published: (2023-12-01)

mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses
by: Parisa Azimi, et al.
Published: (2024-05-01)

Multiomics integration reveals the effect of Orexin A on glioblastoma
by: Sha Yang, et al.
Published: (2023-01-01)

Structure-based discovery of F. religiosa phytochemicals as potential inhibitors against Monkeypox (mpox) viral protein
by: Ranjan K. Mohapatra, et al.
Published: (2024-09-01)

Evaluation of secretome biomarkers in glioblastoma cancer stem cells: A bioinformatics analysis
by: Ehsan Jangholi, et al.
Published: (2024-07-01)

Molecular modeling in drug discovery
by: Temitope Isaac Adelusi, et al.
Published: (2022-01-01)

Molecular docking, drug-likeness and DFT study of some modified tetrahydrocurcumins as potential anticancer agents
by: Ahmed Mahal, et al.
Published: (2024-01-01)

Lipophilicity and ADMET Analysis of Quinoline-1,4-quinone Hybrids
by: Monika Kadela-Tomanek, et al.
Published: (2022-12-01)

Synthesis, antibacterial evaluation, in silico ADMET and molecular docking studies of new N-acylhydrazone derivatives from acridone
by: Mohammed Aarjane, et al.
Published: (2020-07-01)

Snake venom bioprospecting as an approach to finding potential anti-glioblastoma molecules
by: Javier Orozco-Mera, et al.
Published: (2024-09-01)

Editorial: Crop improvement by omics and bioinformatics
by: Jun Li, et al.
Published: (2024-04-01)

Galactoside-Based Molecule Enhanced Antimicrobial Activity through Acyl Moiety Incorporation: Synthesis and In Silico Exploration for Therapeutic Target
by: Faez Ahmmed, et al.
Published: (2023-07-01)

Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach
by: Shopnil Akash, et al.
Published: (2023-03-01)

High-throughput virtual screening of marine algae metabolites as high-affinity inhibitors of ISKNV major capsid protein: An analysis of in-silico models and DFT calculation to find novel drug molecules for fighting infectious spleen and kidney necrosis virus (ISKNV)
by: Sk Injamamul Islam, et al.
Published: (2023-06-01)

Corrigendum: Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: a computational drug design approach
by: Shopnil Akash, et al.
Published: (2023-06-01)

Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma
by: Margaux Fresnais, et al.
Published: (2021-12-01)

Exploring the Action Mechanism of Yadanzi (<i>Brucea javanica</i>) in the Treatment of Glioblastoma Based on Bioinformatics and Network Pharmacology
by: Wenyu Zhao, et al.
Published: (2022-06-01)

Discovery of putative natural compounds inhibitor of the germinant spore receptor CspC in Clostridioides difficile infection: Gaining insights via In silico and bioinformatics approach
by: Oluwatosin A. Saibu, et al.
Published: (2023-01-01)

Phytotherapy for the Treatment of Glioblastoma: A Review
by: Shan Yasin Mian, et al.
Published: (2022-03-01)